Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$51.97 - $63.0 $941,176 - $1.14 Million
-18,110 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.8 - $52.47 $82,544 - $140,619
2,680 Added 17.37%
18,110 $950,000
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $75,061 - $134,000
-2,643 Reduced 14.62%
15,430 $517,000
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $135,581 - $174,863
3,734 Added 26.04%
18,073 $819,000
Q3 2019

Nov 13, 2019

SELL
$35.66 - $44.99 $271,336 - $342,328
-7,609 Reduced 34.67%
14,339 $546,000
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $802,638 - $1.05 Million
21,948 New
21,948 $955,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.12B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.